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Abstract
Background: In human malaria, the naturally-acquired immune response can result in either the elimination of the
parasite or a persistent response mediated by cytokines that leads to immunopathology. The cytokines are
responsible for all the symptoms, pathological alterations and the outcome of the infection depends on the
reciprocal regulation of the pro and anti-inflammatory cytokines. IL-10 and IFN-gamma are able to mediate this
process and their production can be affected by single nucleotide polymorphisms (SNPs) on gene of these
cytokines. In this study, the relationship between cytokine IL-10/IFN-gamma levels, parasitaemia, and their gene
polymorphisms was examined and the participation of pro-inflammatory and regulatory balance during a natural
immune response in Plasmodium vivax-infected individuals was observed.
Methods: The serum levels of the cytokines IL-4, IL-12, IFN-gamma and IL-10 from 132 patients were evaluated by
indirect enzyme-linked immunosorbent assays (ELISA). The polymorphism at position +874 of the IFN-gamma gene
was identified by allele-specific polymerase chain reaction (ASO-PCR) method, and the polymorphism at position
-1082 of the IL-10 gene was analysed by PCR-RFLP (PCR-Restriction Fragment Length Polymorphism).
Results: The levels of a pro- (IFN-gamma) and an anti-inflammatory cytokine (IL-10) were significantly higher in P.
vivax-infected individuals as compared to healthy controls. The IFN-gamma levels in primoinfected patients were
significantly higher than in patients who had suffered only one and more than one previous episode. The mutant
alleles of both IFN-gamma and IL-10 genes were more frequent than the wild allele. In the case of the IFNG+874
polymorphism (IFN-gamma) the frequencies of the mutant (A) and wild (T) alleles were 70.13% and 29.87%,
respectively. Similar frequencies were recorded in IL-10-1082, with the mutant (A) allele returning a frequency of
70.78%, and the wild (G) allele a frequency of 29.22%. The frequencies of the alleles associated with reduced
production of both IFN-gamma and IL-10 were high, but this effect was only observed in the production of IFN-
gamma.
Conclusions: This study has shown evidence of reciprocal regulation of the levels of IL-10 and IFN-gamma
cytokines in P. vivax malaria, which is not altered by the presence of polymorphism in the IL-10 gene.
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In human malaria, the naturally-acquired immune
response can result in either the elimination of the
infectious agent or a persistent response mediated by
cytokines that leads to immunopathology, with activated
T cells and macrophages, although the mechanisms are
not well understood. High levels of pro-inflammatory
cytokines, such as tumor necrosis factor (TNF), inter-
feron-g (IFN-g) and interleukin-6 (IL-6) have been asso-
ciated with severe pathologies [1-5], whereas low levels
of regulatory cytokines, such as TGF-b and IL-10, have
been associated with acute malaria [6-9]. Many aspects
of this process remain to be understood, including the
effects of cytokines on the control of the immune
response and the differences between the protective and
pathological modulatory effects. The IL-10 cytokine has
an important role as an immunoregulator of the infec-
tions caused by Plasmodium, by neutralizing the effects
of the other cytokines produced by Th1 and CD8 cells,
which are responsible for much of the immunopathol-
ogy associated with the overproduction of IFN-g [8,10].
Infection by Plasmodium vivax induces a specific
immune response by stimulating the release of cytokines
from T cells and other mononuclear cells, which might
have an important role in the parasite clearance by acti-
vating effector immune mechanisms [4]. This produc-
tion of cytokines is an important stimulus of the
phagocytosis that enhances the clearance of parasitized
erythrocytes, but the inflammatory cytokines also med-
iate the pathological alterations that determine the man-
ifestation of symptoms [5,11-13].
In P. vivax malaria, cytokines are released after the schi-
zonts rupture, and elevated levels of TNF have been
detected being released in pulses in paroxysms of synchro-
nous P. vivax malaria and appear to be involved in the
pathogenesis of malarial fever [11,13,14]. Other cytokines
have been detected in P. vivax malaria, including IL-1b,
IL-2, IL-4, IL-6, IL-8, IL-10 and IL-12 [13]. More recently,
the participation of regulatory T cells in infection by P.
vivax was showed [15], suggesting that the balance
between pro and anti-inflammatory cytokines is required
to control the pathological alterations. Comparing asymp-
tomatic individuals and cases described as severe malaria,
a study performed in Brazil showed that the IFN-g:IL-10
ratio was higher in severe cases, while IL-10 levels were
elevated in asymptomatic individuals [5].
In P. falciparum malaria, several studies have
described an association between severe infections and
enhanced pro-inflammatory cytokine response, including
TNF, IL-1b,I L - 6 ,a n dI F N - g [1-3,16]. These cytokines
are responsible for all the symptoms, pathological altera-
tions and the outcome of the infection depends on the
reciprocal regulation of the pro and anti-inflammatory
cytokines. However, the balance between pro and anti-
inflammatory response can be favourable to protection
mediated by cytokine as IFN-g [17,18]. Although many
studies have investigated the serum levels and involve-
ment of cytokines in P. falciparum malaria, little is
known of the pro-inflammatory and regulatory balance
during a natural immune response in P. vivax-infected
individuals.
The factors that affect the production of these
immune response mediators include a number of single
nucleotide polymorphisms (SNPs) in cytokine-encoding
genes, which affect gene expression. In the IFN-g gene,
the polymorphism at position +874 is located within a
putative NFB binding site and impairs the production
of IFN-g [19]. An association has also been observed
between the +874T/T and +874A/A genotypes and high
and low IFN-g production, respectively, in patients with
tuberculosis [20-22]. The IL-10 cytokine has a key regu-
latory role and its encoding gene contains a SNP in the
promoter region (-1082G/A) which results in a reduc-
tion in the production of IL-10 in P. falciparum malaria
[23] and may contribute to the immunopathology of a
number of infectious diseases as leprosy [24], Chlamydia
trachomatis infection [25] and tuberculosis [21,26,27].
As no previous study of P. vivax malaria has reported
on the frequency of these polymorphisms, the relation-
ship between cytokine IL-10/IFN-g levels, parasitaemia,
and their gene polymorphisms were examined. This
study has shown evidence of reciprocal regulation of the
levels of IL-10 and IFN-g cytokines in P. vivax malaria,
which is not altered by the presence of polymorphism in
the IL-10 gene.
Methods
Patients and healthy control
Blood samples for cytokine measure were collected from
a total of 132 patients, who were diagnosed as having P.
vivax infection following examination of their thick
blood smear. After the collection, all patients were given
the standard treatment with 1500 mg of chloroquine in
three days; 600 mg, 450 mg and 450 mg, respectively,
and 30 mg of primaquine on the day diagnosis was
made and in subsequent six days. The subjects in this
group had had few or no previous recorded malarial
infections. The control group was composed of 86
healthy individuals. The age, sex, number of malaria
previous episodes, and history of other infectious dis-
eases of each participant were recorded using a standard
questionnaire. The healthy controls were selected from
local blood donors with no parasitaemia or history of
malaria. Blood samples were collected at the Pará state
blood bank. The mean age (± SD) was 32.07 ± 13.40
years (range 12-68 years) in the infected group and
29.99 ± 9.24 years (18-48 years) in the control. Written
informed consent was obtained from all participants,
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mittee of the Evandro Chagas Institute and conducted
between 2007 and 2008.
Blood collection
Two blood samples were taken from each patient. A fin-
ger tip smear was taken for the parasitological diagnosis,
and then approximately 5 ml of venous blood was col-
lected for the analysis of cytokines. The blood was
drawn aseptically into Vacutainer
® tubes (Becton Dick-
son and company, Franklin Lakes, NJ, USA) and centri-
fuged at 1,200 g for 10 minutes at room temperature.
The serum was separated out and the samples were ali-
quoted and stored at -20°C until assayed.
Parasitological diagnosis
Thick blood smears were stained using 5% Giemsa solu-
tion and examined for Plasmodium species by two
microscopists. Parasite density per μl of blood was esti-
mated by counting the number of parasites per 100
fields. The number of asexual P. vivax was counted and
double-checked blindly by an expert microscopist.
Cytokine assays
The serum levels of the cytokines IL-4, IL-12, IFN-g and
IL-10 were evaluated by indirect enzyme-linked immu-
nosorbent assays (ELISA), using pairs of cytokine-speci-
fic monoclonal antibodies provided by the commercially
available test (BD, Biosciences - Pharmingen, San Diego,
CA, USA). All tests were performed according to the
manufacturer’s instructions. Each plate included a stan-
dard curve of recombinant human cytokine run in par-
allel with the samples, and the limit of detection were
2.0 pg/ml (IL-4 and IL-10), 3.9 pg/ml (IL-12) and 1.0
pg/ml (IFN-g). All samples were measured in duplicate,
and the mean of the two values of optical density was
used for all analyses.
DNA extraction
Genomic DNA was extracted from the peripheral blood
leukocytes of subjects P. vivax infected using proteinase
K digestion and the standard phenol-chloroform proce-
dure [28]. The DNA samples were stored at -20°C until
analysis.
Genotyping of IFNG+874 and IL10-1082 genes
polymorphisms
The polymorphism at position +874 of the IFN-g gene
(rs 2430561) was identified by allele-specific polymerase
chain reaction (ASO-PCR) method [19]. The PCR was
performed in a final volume of 30 μl containing 500 ng
of the total extracted DNA, 0.2 μMo fe a c hd N T P ,5
pmol/μl of each specific primer, 2.0 mM MgCl2,5 0m M
KCl, 10 mM Tris-HCl pH 8.3 and 1.0 U taq DNA
polymerase. The primers sequences used were: IFN-g
(+874) CP: 5’-TCA ACA AAG CTG ATA CTC CA-3’,
IFN-g (+874) T: 5’-TTC TTA CAA CAC AAA ATC
AAA TCT -3’,o rI F N - g (+874) A: 5’-TTC TTA CAA
CAC AAA ATC AAA TCA-3’, which amplify a segment
of 262 bp. The amplification reaction was performed
under the following conditions: initial denaturation at
95°C for 5 minutes, 30 cycles of 40 seconds at 94°C, 40
seconds at 56°C and a final extension of 5 minutes at
72°C. The amplified product was analysed by electro-
phoresis in 2% agarose gel containing 5 μl of ethidium
bromide (10 mg/ml) using transillumination with a
source of ultra-violet light.
The polymorphism at position -1082 of the IL-10 gene
(rs 1800896) was analysed by PCR-RFLP (PCR-Restric-
tion Fragment Length Polymorphism) [29]. PCR was per-
formed in a final volume of 50 μl containing 100 ng of
DNA template, 200 μM of each dNTP, 200 nmol/μlo f
each specific primer, 1.5 mM MgCl2,5 0m MK C l ,1 0
mM Tris-HCl pH 8.3 and 1.0 U taq DNA polymerase.
The following primers sequences used were: IL-10
(-1082) forward 5’-TCT GAA GAA GTC CTG ATG TC
-3’ and reverse 5’- CTC TTA CCT ATC CCT ACT TCC
-3’. The 190 bp amplified product was subsequently incu-
bated for 4 h with MnlI restriction enzyme and visualized
in 4% agarose gel. After digestion the allele A is identified
when is observed two fragment on electrophoresis (125
and 65 bp), whereas the allele G is identified in the pre-
sence of three fragments (93, 65 and 32 bp).
Statistical analysis
To compare the concentrations of cytokines between
i n f e c t e da n dc o n t r o lg r o u pw eu s e dM a n n - W h i t n e y ’sU
and student’s t test. The relationship between levels of
cytokines and parasite density and the number of pre-
vious episodes of malaria was tested using an analysis of
variance. The distribution of genotypes was assessed
according to the Hardy-Weinberg equilibrium. All sta-
tistical analysis was carried out in the BioEstat pro-
gramme [30] and p values of less than 0.05 were
considered statistically significant.
Results
Serum levels of pro- (IFN-g and IL-12) and anti-
inflammatory cytokines (IL-10 and IL-4) in the P. vivax
and control groups
The levels of a pro- (IFN-g) and an anti-inflammatory
cytokine (IL-10) were significantly higher in P. vivax
infected individuals as compared to healthy controls (p <
0.001). The mean concentration of IFN-g was 44.50 ±
75.05 pg/ml in patients with malaria, and 1.47 ± 8.43 pg/
ml in the control group, while the means for IL-10 were
283.80 ± 216.71 pg/ml and 2.07 ± 4.31 pg/ml, respectively.
Concentrations were highly variable in the malaria
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from 0.0 to 586.33 pg/ml in IL-10. The mean concentra-
tion of IL-10 was 6.38 times higher than that of IFN-g.
There was also a positive correlation, but relatively weak
correlation between IL-10 and IFN-g concentrations in the
patients (r = 0.389, p < 0.001). For the other two cytokines,
IL-12 (pro-inflammatory) and IL-4 (anti-inflammatory),
concentrations were very low or undetectable in most sub-
jects, from both groups (Table 1).
IL-10 concentration increases in patients with high
parasite density
The concentrations of IL-10 and IFN-g were highest in
subjects with the highest parasite densities (> 10,000
parasites/μl) in comparison with those with lower densi-
ties (≤ 1,000 parasites/μl), although the difference was
only significant for IL-10 (Table 2). Mean levels of this
cytokine were significantly different when comparing
the lower and higher ranges of parasitaemia (≤ 1,000 vs.
5,001-10,000 parasites/μl: p < 0.05 and ≤ 1,000 vs.>
10,000: p < 0.05). In case of IFN-g, however, the differ-
ences were not significant (p = 0.5671). The correlation
between cytokine levels and parasite densities were low
in both cases, but slightly higher in IL-10 (r = 0.1379) in
comparison with IFN-g (r = 0.0737).
IFN-g levels were higher in patients with primary exposure
to P. vivax malaria than in those with previous exposition
Serum IFN-g and IL-10 levels were also analysed accord-
ing to the number of previous malaria episodes. In the
patients group who had been exposed to only one
malaria episode, IFN-g and IL-10 levels were higher than
in patients who had had at least one previous episode
(Table 2). Serum IFN-g levels in primoinfected patients
(81.84 ± 102.59 pg/ml) were significantly higher (p <
0.05) than in patients who had suffered only one (29.05 ±
58.84 pg/ml) and more than one previous episode (21.41
±4 9 . 4 2pg/ml). A similar pattern was recorded for IL-10,
although the differences were not significant (p > 0.05).
Allele and genotype frequencies obtained for the IFN-g
and IL-10 genes
The mutant alleles of both IFN-g and IL-10 genes were
more frequent than the wild allele. In the case of the
IFNG+874 polymorphism (IFN-g) the frequencies of the
mutant (A) and wild (T) alleles were 70.13% and 29.87%,
respectively (Table 3). The mutant homozygote (AA) was
detected in 50.65% of patients, while the AT and TT gen-
otypes were recorded in 38.96% and 10.39%, respectively.
Similar frequencies were recorded in IL-10-1082 poly-
morphism, with the mutant (A) allele returning a fre-
quency of 70.78%, and the wild (G) allele a frequency of
29.22%. The mutant homozygote (AA) was detected in
49.35% of patients, while the AG and GG genotypes were
recorded in 42.86% and 7.79%, respectively.
Polymorphism affected the production of IFN-g, but not
IL-10
The frequencies of the alleles associated with reduced
production of both IFN-g and IL-10 were high, but this
Table 1 Serum concentrations of IFN-g, IL-10, IL-4 and IL-12 cytokines in P.vivax-infected patients and the control
group
Cytokine Serum cytokine levels (pg/ml)
Mean ± SD
Patients
1 Control group
2 P values
IFN-g 44.50 ± 75.05 (0.0-332.85)
3 1.47 ± 8.43 (0.0-68.09) p< 0.0001
IL-10 283.80 ± 216.71 (0.0-586.33) 2.07 ± 4.31 (0.0-27.51) p< 0.0001
IL-4 0.32 ± 1.48 (0.0-9.75) 0.0 ± 0.0 (0.0-0.0)
IL-12 3.43 ± 12.65 (0.0-99.65) 7.03 ± 14.83 (0.0-80.71)
1IFN-g: n = 132; IL-10: n = 131; IL-4: n = 81; IL-12: n = 78;
2IFN-g: n = 86; IL-10: n = 77; IL-4: n = 78; IL-12: n = 77;
3Range of values.
Table 2 Effects of IFN-g and IL-10 cytokines on parasite density and levels in primary exposure to P.vivax malaria
Serum cytokine concentration (rg/ml) Mean ± SD according to:
Parasites/μl Number of previous malaria episodes
Cytokine ≤ 1000
(n = 30)
1001 - 5000
(n = 34)
5001 - 10000
(n = 38)
> 10000
(n = 19)
0 episode
(n = 12)
1 episode
(n = 32)
> 1 episode
(n = 41)
IFN-g 30.87 ± 71.26
(0.0-324.55)
1
37.81 ± 69.95
(0.0-287.69)
49.08 ± 71.99
(0.0-332.85)
63.22 ± 77.67
(0.0-298.88)
81.84 ± 102.59
(0.0-287.69)
29.05 ± 58.84
(0.0-298.88)
21.41 ± 49.42
(0.0-281.70)
IL-10 172.68 ± 84.56
(0.0-573.11)
298.77 ± 222.40
(4.06-576.89)
324.34 ± 212.07
(0.75-586.33)
364.31 ± 13.57
(0.0-579.41)
326.47 ± 196.09
(65.28-570.59)
184.78 ± 189.08
(0.0-533.45)
265.96 ± 215.08
(0.0-570.59)
1Range of values.
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(Table 4). In the case of the IFNG+874 polymorphism,
the mean serum concentration of IFN-g was significantly
l o w e r( p=0 . 0 1 8 6 )i nt h eg r o u pw i t ht h eA Ag e n o t y p e
(30.85 ± 54.22 pg/ml) in comparison with carriers of the
wild T allele (76.60 ± 99.54 pg/ml). Despite this differ-
ence, no significant difference was found between geno-
types in mean parasite density (p = 0.4348), indicating
that the IFNG+874 polymorphism does not affect the
parasitaemia (Table 4). In the case of the IL10-1082
polymorphism, mean serum IL-10 levels were slightly
lower for the AA genotype (301.47 ± 213.30 pg/ml) in
comparison with carriers of the G allele (360.84 ±
199.00 pg/ml), this difference was not significant, indi-
cating that IL10-1082 polymorphism does not affect IL-
10 production in P. vivax malaria.
In order to confirm that the IFNG+874 and IL10-1082
polymorphisms had no influence in the mechanisms of
control or elimination of parasites, the parasite densities
in patients with mutant alleles for only one or both of the
genes were compared (Table 5). No association between
these genotypes and parasite density was observed.
Discussion
The levels of both the pro- (IFN-g) and anti-inflamma-
tory (IL-10) cytokines were significantly higher in P.
vivax-infected patients compared with healthy controls.
However, serum levels of IL-12 and IL-4 cytokines were
not detected. The concentration of IL-10 was higher in
the group with high parasite density. This indicates that
IL-10 has an important regulatory role in malaria infec-
tion, controlling the intensity of the immune response,
as has been described in malaria experimental model
and human malaria and in a number of other infectious
diseases [7-9,31].
The immunopathogy of malaria is dependent on both
the Plasmodium species involved and the regulatory
mechanisms dependent on CD4 T cells. Recent studies
comparing asymptomatic and severe P. vivax malaria
suggest that IL-10 may be important for promoting pro-
tective immunity [5]. However, the factors responsible
for the activation and regulation mediated by IL-10, and
the timing of these controls, are not well understood.
Increased levels of inflammatory cytokines have been
observed in cases of severe malaria. In P. vivax malaria,
the IFN-g serum level and the IFN-g:IL-10 ratio were
higher in patients with increased disease severity [5]. In
severe P. falciparum malaria, the levels of both IFN-g
and IL-6 and the IL-6:IL-10 ratio were increased [1]. In
this study, we observed the production of both pro
(IFN-g) and anti-inflammatory (IL-10) cytokines during
infection, but IL-10 production increased when the
parasite density was elevated. This study has identified
for the first time a polymorphism in IL-10 gene in P.
vivax malaria patients. As IL-10 is an effective regula-
tory cytokine, it is important to confirm its production
levels and association with high parasite densities, and
in particular, that the polymorphism (IL10-1082) does
not affect its expression. The overall magnitude of the
production and the imbalances between pro- and anti-
inflammatory cytokines have been proposed as poten-
tially important determinants of the control or exacerba-
tion of clinical manifestations [8].
T h er o l eo fI F N - g and IL-10 has been described in P.
falciparum malaria [8,17,18,32,33]. In the case of P.
vivax malaria, studies in Brazil [34], Turkey [13], South
Korea [35,36], and India [37] have analysed the produc-
tion of these two cytokines, but have not recorded the
Table 3 Allele and genotype frequencies of the IFNG+874
and IL10-1082 polymorphisms
Polymorphism Frequency
IFN-g (IFNG+874) Allele n (%) Genotypes n (%)
A 108 (70.13) AA 39 (50.65)
T 46 (29.87) AT 30 (38.96)
Total 154 (100.00) TT 8 (10.39)
Total 77 (100.00)
IL-10 (IL10-1082) Allele n (%) Genotypes n (%)
A 109 (70.78) AA 38 (49.35)
G 45 (29.22) AG 33 (42.86)
Total 154 (100.00) GG 6 (7.79)
Total 77 (100.00)
Table 4 Effect of genotype on serum concentrations of IFN-g and IL-10 cytokines and parasite density
Genotype (n) Serum cytokine level (pg/ml)
Mean ± SD
Parasites/μl
Mean ± SD
IFNG+874 AA (39) 30.85 ± 54.22 (0.0-281.70)
1 5126 ± 4779.98 (12-20000)
IFNG +874 AT and TT (38) 76.60 ± 99.54 (0.0-332.85) 5917.76 ± 7516.64 (25-40000)
P 0.0186 0.4348
IL10-1082 AA (38) 301.47 ± 213.30 (4.68-578.46) 5287.49 ± 7392.26 (12-40000)
IL10-1082 AG and GG (39) 360.84 ± 199.00 (37.11-586.33) 5760 ± 5076.04 (200-20000)
P 0.1064 0.833
1Range of values.
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group of patients.
The comparison among groups with different levels of
clinical manifestations has shown that in cases of mild
P. vivax, the balance was in favour of IL-10, and the
serum levels were significantly different between the
groups with < 1,000 parasites/μl and > 10,000 parasites/
μl. However, there was only a weak correlation between
IL-10 concentrations and the number of parasites in the
peripheral blood. This result may reflect the fact that
the number of parasites in the bloodstream at a given
moment may not always to show the maximum immu-
nogenic potential able to induces response immune in
the host, because part of the parasite’s antigens can be
in tissues of the immune system and not only in the
blood.
The balance between pro- and anti-inflammatory cyto-
k i n e si sc o n s i s t e n tw i t ht h ei n d u c t i o no ft h er e g u l a t i o n
of the immune response against P. vivax malaria and it
has been confirmed by an increase in the number of
Treg CD25
+ cells during infection [15] and detection of
high IL-10 levels in asymptomatic P. vivax malaria [5],
indicating that the control was effective without provok-
ing an imbalance of pro- or anti-inflammatory cytokines.
An increase in the percentage of FOXP3
+ Treg cells,
IL-10-secreting Type I Treg cells (Tr1) and IL-10 levels
has been recorded during acute P. vivax infection. The
role of regulatory T cells has been confirmed in vivo
and in vitro after stimulation of PBMC with crude anti-
gens extracted from P. vivax-infected red blood cells,
and it has been postulated that IL-10 can lead to a state
of immunosuppression in P. vivax malaria by modulat-
ing different populations of cells, including a decrease in
the number or activation of DCs [38]. This study con-
firms that this control can be mediated by IL-10, and
suggests that the number of parasites can modulate the
expression of the cytokine genes. While this and other
studies are starting to some shed light on the participa-
tion of IL-10 in P. vivax malaria, many aspects of the
regulatory response are not yet fully understood.
The analysis showed no significant association
between the polymorphisms in the genes codifying INF-
g and IL-10 and the control of the parasitaemia.
Although IL-12, INF-g and IL-10 have been shown to
play a significant role in the adaptive immune response
in patients with P. vivax malaria [13,34], the IL-10 and
INF-g were detected, but not IL-12. The serum concen-
trations of IL-10 were similar to those found in patients
from Brazil [34], but much higher than the levels
recorded in patients from Turkey [13]. The levels of IL-
10 were also elevated in P. vivax patients with fever [36]
or hepatic dysfunction [39]. These results indicate that
the serum levels of this cytokine may vary under differ-
ent clinical conditions of the patients.
As IL-10 may exert its suppressive effects on INF-g
by down-regulation, it has been postulated that this
mechanism may occur in other cytokines, including
IL-12. Regulation of IFN-g by IL-10 has been shown
in vitro by adding anti-IL-10 human antibodies to
PBMC cultures obtained from umbilical cords, which
were stimulated with infected erythrocytes [40]. How-
ever, additional studies performed with samples col-
lected at different time points throughout the course
of P. vivax infection and the analysis of other cyto-
kines with important roles in the induction and regu-
lation of immunity to the intracellular stages of the
parasite will be required to better evaluate their inter-
relationship.
Different levels of cytokines concentrations were
observed in Brazilian patients when compared with
cytokines detected in the serum of the patients from
Turkey [13], in which IL-4 and IL-12 were recorded, but
the concentration of IFN-g was not presented. Another
study performed in Brazil found increased concentra-
tions of IFN-g in patients infected with P. vivax or P.
falciparum, but increased IL-10 was observed only in P.
vivax patients. In this study was confirmed the partici-
pation of IL-10, as described in previous studies [13,36],
and the lack of any effect of the polymorphism in IL-10
gene on the production of this cytokine suggests that
the maintenance of IL-10 is essential to the immune
response.
The serum levels of IFN-g varied considerably among
individuals, although mean concentrations were lower
than those recorded in a previous study of P. vivax
patients from the Brazilian Amazonian, state of Pará
[34]. These differences may arise from a combination of
factors, such as the kinetics of the production of this
cytokine and the patient’s condition, given that IFN-g
levels may increase during fever episodes [36]. The IFN-
g concentration in P. vivax patients from South Korea
who not had no hepatic dysfunction was low, whereas
Table 5 Effect of association of the polymorphisms IFNG +874 and IL10-1082 on the parasite density
Genotype Parasites/μl Mean ± SD P
IFNG+874AA + IL10-1082 AA (n = 19)
IFNG+874AT or TT + IL10-1082 AG or GG (n = 20)
4840.0 ± 5160.46 (12-20000)
1
6060.0 ± 5664.14 (200-20000)
0.2436
IFNG+874AT or TT + IL10-1082 AA(n = 17)
IFNG+874AA + IL10-1082 AG or GG (n = 18)
3745.59 ± 3862.58 (25-12000)
5427.78 ± 4472.11 (200-17500)
0.0880
1Range of values.
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ders [39]. With regards to IFN-g, this is an important
finding because this cytokine is associated with the cel-
lular response, and few studies of the cellular immune
response in P. vivax malaria are available.
The production of both IFN-g [41-45] and IL-10
[43-45] have been shown in PBMC culture stimulated
with recombinant proteins containing antigens from
blood stages of P. vivax. These studies indicates that
antigen from P. vivax activates Th1 pathway, however,
as few studies were performed, and this polarization of
the subpopulation of lymphocytes remains controversial,
further investigation may confirm more clearly the parti-
cipation either Th1 and/or Th2 pathway in the protec-
tive response against P. vivax.
The production of IFN-g is probably one of the most
physiologically relevant effects mediated by IL-12 in the
presence of inflammatory or immune stimuli, but in this
study IL-12 was not detected. Similar results have been
obtained for IL-12 in severe P. falciparum malaria [46].
With regards to P. vivax malaria, studies have detected
IL-12, but not IL-4 in the same samples [13,34] or low
IL-4 levels in cases with both hepatic disorders and nor-
mal liver function, whereas levels of IL-12 were high
[39].
The concentration of IL-12 appears to increase at the
beginning of the immune response, as observed in the
in vitro study, which demonstrated an increase in the
IL-12p40 transcripts in the first 24 hours after stimula-
tion of PBMC with P. falciparum antigens, and a subse-
quent decrease to the basal level in 48 hours [46]. So,
one explanation of our results would be that the con-
centration of this cytokine was at the basal level when
the samples were collected. Another possibility is that
IL-12 is regulated by IL-10 during this phase of the
immune response [47-49], so that the cytokine that
mediates this regulation may be present at higher con-
centrations. This suggests that IL-10 exerts suppressive
effects on IL-12 through down-regulation. For a more
conclusive analysis of this phenomenon, additional stu-
dies of samples collected prospectively throughout the
course of the P. vivax infection will be necessary.
The participation of IL-4 in the humoral immune
response to malaria involves the production of class
IgG1 and IgG3 antibodies, which are involved in the
response against the antigens of parasite erythrocytic
stages [41,44,45]. While this antibody response has been
well-documented in other studies, IL-4 cytokine produc-
tion was not detected in response to P. vivax,T h i sm a y
indicate that the humoral immune response to malaria
can be sustained independently of the production of IL-
4, or that the serum concentrations of this cytokine may
be alternate considerably over the course of the infec-
tion. On the other hand, the association between low
levels of IL-4 and high of IL-10 suggests that, in this
phase of the disease, the participation of the regulatory
cytokine can be more important than the response
mediated by cytokines from Th2 cells. In P. falciparum
malaria, reduced serum levels of IL-4 has been
described, indicating the participation of IL-10 in the
regulation of the response mediated by IL-4 in P. falci-
parum malaria [16].
The high serum concentrations of IFN-g were not
associated with any reduction in the parasitaemia, which
indicates no effective control of infection, in contrast
with the evidence for P. falciparum malaria [33]. This
may occur as a form of protection for the host, by
avoiding an exacerbated response mediated by INF-g.I n
addition, the production would be also negatively regu-
lated by IL-10, and the parasite density may increase
when the pro-inflammatory response is regulated by IL-
10. This conclusion is corroborated by another study,
which had recorded a positive correlation between the
levels of IL-10 and parasite density in P. vivax patients
[13].
The production of IFN-g was higher in patients suffer-
ing their first exposure to malaria, suggesting that the
e f f e c t o rr e s p o n s em a yb em o r ei n t e n s ed u r i n gt h ef i r s t
infection. In the case of IL-10, previous exposure to the
parasite did not affect this cytokine production. This
may be at least partly explained by the inefficiency of
the cloning of memory cells. In malaria, protective
immunity is acquired gradually through the natural
exposure of individuals who live in areas where the dis-
ease is endemic, but this immunity is rapidly lost when
this exposure ceases, indicating that the immunological
memory of malaria is short-term, and requires constant
exposure to the parasite [50,51].
The polymorphisms at position +874 of the gene that
codifies IFN-g and at position -1082 in the IL-10 gene
was also investigated in order to establish whether the
mutant homozygote genotypes are associated with
reduced productivity of these cytokines, as well as ana-
lysing the possible implications of these polymorphisms
for the parasite density in P. vivax malaria. While no
previous research has focused on these polymorphisms
in P. vivax malaria, a recent study analysed polymorph-
isms in the promoter region of the gene that codifies for
TNF, and showed that allele A at position -308 and
allele C at position -1031 are associated with increased
serum levels of this cytokine, although there was no
apparent effect on susceptibility to P. vivax malaria [52].
The A and T alleles of the IFNG+874 polymorphism
had frequencies of 0.70 and 0.30, respectively, while in
the IL10-1082 polymorphism, the frequencies of the A
and G alleles were 0.71 and 0.29. These frequencies
were similar to those obtained in studies of other infec-
tious [53] and non-infectious diseases [54,55]. A study
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patients [53] recorded frequencies of 0.63 and 0.37,
respectively, for the A and T alleles in patients with the
cutaneous form of the disease, and 0.67 and 0.33 in
those with the mucosal form.
In the IFNG+874 polymorphism, the homozygote
mutant AA genotype was the most common, followed
by AT and TT, the frequencies were, 0.51, 0.39 and,
0.10, respectively. These frequencies are similar to those
found in patients with leishmaniasis [53] and tuberculo-
sis [21]. The patients with the AA genotype had reduced
serum levels of IFN-g, while carriers of the wild allele
(AT and TT) had high levels of this cytokine. This situa-
tion is similar to that found in studies of the Mycobac-
terium tuberculosis antigen [20,21] and antigens of the
Leishmania braziliensis promastigote [53], which
recorded low, medium, and high levels of IFN-g, respec-
tively, in the AA, AT, and TT genotypes.
The homozygote mutant (AA) was also the most com-
mon genotype in the IL10-1082 polymorphism, with a
frequency of 0.49, in comparison with 0.43 for AG, and
0.08 for GG. Similar genotype frequencies were recorded
in patients with severe anemia caused by P. falciparum
[23]. The carriers of the wild allele (AG and GG) pre-
sented serum IL-10 levels higher than those with the
homozygote mutant (AA), although the difference was
not significant. The IL10-1082 polymorphism also had
little effect on IL-10 levels in culture cells stimulated by
M. tuberculosis antigens [27]. This study shows that
neither polymorphism nor any combination of geno-
types was associated with differences in the elimination
of the parasite, as described for P. falciparum patients
[56]. Taken together, our results suggest that a negative
regulation mediated by IL-10 and the polymorphism in
IFN-g gene (IFNG+874) provides a control mechanism
in P. vivax malaria. As production of the regulatory
cytokine IL-10 was not affected by the polymorphism in
its gene, these preliminary results suggest that the cyto-
kines which activate effector mechanisms may be more
susceptible to alterations than that the regulatory cyto-
kine. In general, the resolution of infection requires a
coordinated response in which initial pro-inflammatory
mechanisms clear the parasite and then are down-
modulated by IL-10 before pathology occurs.
This study has provided a first analysis of the poly-
morphisms in IFN-g and IL10 genes, and confirmed the
regulatory role of IL-10 in P. vivax malaria, which is not
affected by this polymorphism. Moreover, increased IL-
10 and IFN-g in P. vivax malaria suggest a reciprocal
regulation. Further immunological and molecular epide-
miological studies are necessary in order to better
understand the immunomodulation in both immuno-
pathology and protective immune response scenarios in
Plasmodium vivax malaria, essential for to development
vaccines as well as new immunotherapeutics targets.
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